VNO heads into its August 3 earnings report with a fresh Morgan Stanley downgrade landing just as the stock trades around analyst price targets — a collision of improving sentiment and renewed caution.
Morgan Stanley's Ronald Kamdem cut Vornado to Underweight this morning, keeping his $32 target unchanged even as the stock trades at $39.97. That gap is striking. Kamdem's move comes one day after a burst of target-price upgrades: Piper Sandler lifted its Neutral target from $28 to $42, Mizuho raised its Outperform target from $34 to $42, Barclays pushed its Underweight target from $29 to $34, and Scotiabank moved from $38 to $40 while staying at Sector Perform. The aggregate picture is a Street that acknowledges the rally but is divided on whether the current price is justified — the consensus remains a Hold, with two Sells, six Holds, and no Buy ratings in the formal count.
The bull and bear cases are sharply drawn. Bulls point to Vornado's dominant Penn District position, solid leasing activity, and financial flexibility for buybacks and joint-venture structures. Bears focus on the capital intensity of PENN 15, which still lacks committed anchor tenants, and the lingering uncertainty around a potential 350 Park Avenue stake — a deal with Citadel where the leasing picture remains unsettled. With the stock now near or above most neutral targets, the Morgan Stanley downgrade reflects a view that the easy money from the discount-to-NAV recovery trade has been largely captured.
Positioning in the lending market tells a comfortable story for the bulls. Short interest has fallen roughly 13% over the past month, dropping to 5.4% of free float — still meaningful for a REIT but moving in the right direction. Availability is exceptionally loose at 621%, meaning there are more than six shares available to borrow for every one already shorted. Borrowing costs are minimal at 0.44%. None of this suggests a crowded or stressed short book. Options positioning reinforces the lack of anxiety: the put/call ratio is at 0.27, well below its 20-day average of 0.33 and near its 52-week low of 0.26. That is about as call-skewed as this name gets, consistent with investors leaning into the rally rather than hedging against it.
The insider register offers a contrasting data point worth noting. Trustee Michael Fascitelli sold roughly 133,000 shares at $36.57–$37.34 in mid-June, taking out approximately $4.9 million. That sale came when the stock was already recovering — not at the lows — which removes the obvious "tax-driven" or "distress" read. The other notable recent activity is a cluster of buys in late February and early March by Independent Trustee Daniel Tisch, who accumulated around 210,000 shares at prices between $25.55 and $27.85. Those purchases aged well; the stock is now more than 45% above those levels.
Recent earnings history adds texture before the August 3 print. The last two results triggered meaningful moves: a 6.4% gain the next day after the May 5 release, and a 1.2% gain after the May 21 event, with five-day follow-throughs of 5.3% and 7.1% respectively. The pattern suggests the stock has rewarded positive surprises more consistently than it has punished misses. Peer performance has also been broadly constructive this week — HIW gained 3.1% and CUZ added 2.5%, while HPP fell 6.2%, suggesting office REIT performance is diverging sharply by asset quality and geography.
The tension heading into August 3 is whether Vornado can deliver enough on leasing progress and PENN District updates to justify a stock price that has now moved past several neutral analyst targets — with Morgan Stanley's freshly downgraded Underweight adding a credentialed dissent to the bullish consensus.
See the live data behind this article on ORTEX.
Open VNO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
